1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Sofosbuvir 400 MG plus Daclatasvir 200mg: new trials by email Literature Review of Sofosbuvir 400 MG plus Daclatasvir 200mg trials Research Report on Sofosbuvir 400 MG plus Daclatasvir 200mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) Sofosbuvir 400 MG plus Daclatasvir 200mg - COVID-19 | Phase 3 | Unknown | Mansoura University | 50 | 2020-12-28 | 2021-02-24 |
COVID-19 (1)
Egypt (1)